From Novant Health “Our research team’s par
Post# of 148288
(Total Views: 646)
Posted On: 04/07/2020 8:05:12 PM
From Novant Health
“Our research team’s partnership with CytoDyn has enabled us to enroll Novant Health patients in this trial just four days after our organizations first made contact,” said Mark King, vice president, research & innovation, Novant Health. “I am grateful for the opportunity to work alongside CytoDyn’s team of professionals, who share our commitment to swiftly finding the treatment our patients and communities need.”
https://myfox8.com/news/coronavirus/novant-he...treatment/
“Our research team’s partnership with CytoDyn has enabled us to enroll Novant Health patients in this trial just four days after our organizations first made contact,” said Mark King, vice president, research & innovation, Novant Health. “I am grateful for the opportunity to work alongside CytoDyn’s team of professionals, who share our commitment to swiftly finding the treatment our patients and communities need.”
https://myfox8.com/news/coronavirus/novant-he...treatment/
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
Scroll down for more posts ▼